Similar articles

• Phase II trial of continuous dose-intense temozolomide in recurrent malignant glioma: RESCUE study.

  Perry JR, Bélanger K, Mason WP, Fulton D, Kavan P, Easaw J, Shields C, Kirby S, Macdonald DR, Eisenstat DD, Thiessen B, Forsyth P, Pouliot JF. Perry JR, et al. J Clin Oncol. 2010 Apr 20;28(12):2051-7. doi: 10.1200/JCO.2009.26.5520. Epub 2010 Mar 22. J Clin Oncol. 2010. PMID: 20308655 Clinical Trial.
• NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide.

  Wick W, Hartmann C, Engel C, Stoffels M, Felsberg J, Stockhammer F, Sabel MC, Koeppen S, Ketter R, Meyermann R, Rapp M, Meisner C, Kortmann RD, Pietsch T, Wiestler OD, Ernemann U, Bamberg M, Reifenberger G, von Deimling A, Weller M. Wick W, et al. J Clin Oncol. 2009 Dec 10;27(35):5874-80. doi: 10.1200/JCO.2009.23.6497. Epub 2009 Nov 9. J Clin Oncol. 2009. PMID: 19901110 Clinical Trial.
• An Australian experience with temozolomide for the treatment of recurrent high grade gliomas.

  Harris MT, Rosenthal MA, Ashley DL, Cher L. Harris MT, et al. J Clin Neurosci. 2001 Jul;8(4):325-7. doi: 10.1054/jocn.2000.0809. J Clin Neurosci. 2001. PMID: 11437571
• Temozolomide: therapeutic limitations in the treatment of adult high-grade gliomas.

  Chamberlain MC. Chamberlain MC. Expert Rev Neurother. 2010 Oct;10(10):1537-44. doi: 10.1586/ern.10.32. Expert Rev Neurother. 2010. PMID: 20925470 Review.
• Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas.

  Brandsma D, Stalpers L, Taal W, Sminia P, van den Bent MJ. Brandsma D, et al. Lancet Oncol. 2008 May;9(5):453-61. doi: 10.1016/S1470-2045(08)70125-6. Lancet Oncol. 2008. PMID: 18452856 Review.